421 related articles for article (PubMed ID: 22362921)
1. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.
Busse K; Heilmann R; Kleinschmidt S; Abu-Mugheisib M; Höppner J; Wunderlich C; Gemende I; Kaulitz L; Wolters A; Benecke R; Walter U
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):441-7. PubMed ID: 22362921
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
López Hernández N; García Escrivá A; Shalabi Benavent M
Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
[TBL] [Abstract][Full Text] [Related]
3. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
[TBL] [Abstract][Full Text] [Related]
4. Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.
Berg D; Seppi K; Liepelt I; Schweitzer K; Wollenweber F; Wolf B; Dillmann U; Stockner H; Godau J; Kiechl S; Gaenslen A; Willeit J; Di Santo A; Maetzler W; Gasser T; Poewe W; Behnke S
Mov Disord; 2010 Jul; 25(10):1464-9. PubMed ID: 20629151
[TBL] [Abstract][Full Text] [Related]
5. Frequency and profile of Parkinson's disease prodromi in patients with malignant melanoma.
Walter U; Heilmann E; Voss J; Riedel K; Zhivov A; Schäd SG; Gross GE; Benecke R; Trcka J
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):302-10. PubMed ID: 25817520
[TBL] [Abstract][Full Text] [Related]
6. A population-based study on combined markers for early Parkinson's disease.
Tunc S; Graf J; Tadic V; Brüggemann N; Schmidt A; Al-Khaled M; Wolff S; Vollstedt EJ; Lorwin A; Hampf J; Piskol L; Klein C; Hagenah J; Kasten M
Mov Disord; 2015 Apr; 30(4):531-7. PubMed ID: 25546094
[TBL] [Abstract][Full Text] [Related]
7. Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study.
Mahlknecht P; Stockner H; Marini K; Gasperi A; Djamshidian A; Willeit P; Kiechl S; Willeit J; Rungger G; Poewe W; Seppi K
Parkinsonism Relat Disord; 2020 Jan; 70():51-54. PubMed ID: 31864071
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
9. Predictors for mild parkinsonian signs: a prospective population-based study.
Mahlknecht P; Kiechl S; Stockner H; Willeit J; Gasperi A; Poewe W; Seppi K
Parkinsonism Relat Disord; 2015 Mar; 21(3):321-4. PubMed ID: 25585991
[TBL] [Abstract][Full Text] [Related]
10. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.
Liepelt I; Behnke S; Schweitzer K; Wolf B; Godau J; Wollenweber F; Dillmann U; Gaenslen A; Di Santo A; Maetzler W; Berg D
Neurobiol Aging; 2011 Sep; 32(9):1599-606. PubMed ID: 19897277
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
12. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
[TBL] [Abstract][Full Text] [Related]
13. Transcranial brain sonography for Parkinsonian syndromes.
Bor-Seng-Shu E; Paschoal FM; Almeida KJ; De Lima Oliveira M; Nogueira RC; Teixeira MJ; Walter U
J Neurosurg Sci; 2019 Aug; 63(4):441-449. PubMed ID: 31210040
[TBL] [Abstract][Full Text] [Related]
14. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
[TBL] [Abstract][Full Text] [Related]
15. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.
Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J
Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434
[TBL] [Abstract][Full Text] [Related]
16. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
[TBL] [Abstract][Full Text] [Related]
17. [Transcranial sonography in Parkinson's disease].
Fedotova EIu; Chechetkin AO; Shadrina MI; Slominskiĭ PA; Ivanova-Smolenskaia IA; Illarioshkin SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(1):49-55. PubMed ID: 21350412
[TBL] [Abstract][Full Text] [Related]
18. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease.
Huang YW; Jeng JS; Tsai CF; Chen LL; Wu RM
Mov Disord; 2007 Mar; 22(4):550-5. PubMed ID: 17260344
[TBL] [Abstract][Full Text] [Related]
19. Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.
Laučkaitė K; Rastenytė D; Šurkienė D; Vaitkus A; Sakalauskas A; Lukoševičius A; Gleiznienė R
BMC Neurol; 2012 Mar; 12():12. PubMed ID: 22400906
[TBL] [Abstract][Full Text] [Related]
20. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
